Inhibitor of suv39h1 histone methyltransferase for use in cancer combination therapy
US-2024216388-A1 · Jul 4, 2024 · US
US2017088872A1 · US · A1
| Field | Value |
|---|---|
| Publication number | US-2017088872-A1 |
| Application number | US-201615242525-A |
| Country | US |
| Kind code | A1 |
| Filing date | Aug 20, 2016 |
| Priority date | Aug 21, 2015 |
| Publication date | Mar 30, 2017 |
| Grant date | — |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention provides compositions and methods for biosynthetically producing podophyllotoxin intermediates and derivatives including enzymes and their equivalents involved in the biosynthetic production of podophyllotoxin intermediates and derivatives.
Opening claim text (preview).
What is claimed is: 1 . An isolated nucleic acid molecule encoding an enzyme involved in synthesizing podophyllotoxin intermediates and derivatives and having at least 90% sequence identity to nucleic acid SEQ ID NO:1, and conservative variants thereof. 2 . An isolated nucleic acid molecule encoding an enzyme involved in synthesizing podophyllotoxin intermediates and derivatives and having at least 90% sequence identity to nucleic acid SEQ ID NO:2, and conservative variants thereof. 3 . An isolated nucleic acid molecule encoding an enzyme involved in synthesizing podophyllotoxin intermediates and derivatives and having at least 90% sequence identity to nucleic acid SEQ ID NO:3, and conservative variants thereof. 4 . An isolated nucleic acid molecule encoding an enzyme involved in synthesizing podophyllotoxin intermediates and derivatives and having at least 90% sequence identity to nucleic acid SEQ ID NO:4, and conservative variants thereof. 5 . An isolated nucleic acid molecule encoding an enzyme involved in synthesizing podophyllotoxin intermediates and derivatives and having at least 90% sequence identity to nucleic acid SEQ ID NO:5, and conservative variants thereof. 6 . An isolated nucleic acid molecule encoding an enzyme involved in synthesizing podophyllotoxin intermediates and derivatives and having at least 90% sequence identity to nucleic acid SEQ ID NO:6, and conservative variants thereof. An isolated nucleic acid molecule encoding an enzyme involved in synthesizing podophyllotoxin intermediates and derivatives and having at least 90% sequence identity to nucleic acid SEQ ID NO:7, and conservative variants thereof. 8 . An isolated nucleic acid molecule encoding an enzyme involved in synthesizing podophyllotoxin intermediates and derivatives and having at least 90% sequence identity to nucleic acid SEQ ID NO:8, and conservative variants thereof. 9 . An isolated nucleic acid molecule encoding an enzyme involved in synthesizing podophyllotoxin intermediates and derivatives and having at least 90% sequence identity to nucleic acid SEQ ID NO:9, and conservative variants thereof. 10 . An isolated nucleic acid molecule encoding an enzyme involved in synthesizing podophyllotoxin intermediates and derivatives and having at least 90% sequence identity to nucleic acid SEQ ID NO:10, and conservative variants thereof. 11 . A vector comprising one or more of the nucleic acid molecules according to any of claims 1 - 10 , wherein said one or more nucleic acid molecule is operably linked to a nucleic acid molecule comprising a promoter sequence, conferring expression of one or more enzymes involved in synthesizing podophyllotoxin intermediates and derivatives. 12 . A host cell comprising one or more of the nucleic acid molecules according to any of claims 1 - 10 for use in expressing enzymes involved in synthesizing podophyllotoxin intermediates and derivatives. 13 . A host cell for producing 4′-desmethylepipodophyllotoxin, comprising nucleic acid SEQ ID NO:1 for converting pinoresinol to secoisolariciresinol; nucleic acid SEQ ID NO:2 for converting secoisolariciresinol to matairesinol; nucleic acid SEQ ID NO:3 for converting matairesinol to pluviatolide; nucleic acid SEQ ID NO:4 for converting pluviatolide to 5′-desmethoxy-yatein; nucleic acid SEQ ID NO:5 for converting 5′-desmethoxy-yatein into 5′-desmethyl-yatein; nucleic acid SEQ ID NO:6 for converting 5′-desmethyl-yatein into yatein; nucleic acid SEQ ID NO:7 for converting yatein into deoxypodophyllotoxin; nucleic acid SEQ ID NO:8 for converting deoxypodophyllotoxin into 4′-desmethyl-deoxypodophyllotoxin; and nucleic acid SEQ ID NO:9 for converting 4′-desmethyl-deoxypodophyllotoxin into 4′-desmethyl-epipodophyllotoxin. 14 . The host cell of claim 12 , wherein the host cell is a plant, yeast, bacterial, insect or mammalian cell. 15 . The host cell of claim 13 , wherein the host cell is a plant, yeast, bacterial, insect or mammalian cell. 16 . The host cell of claim 13 , furthermore comprising nucleic acid SEQ ID NO:10 or a conservative variant thereof. 17 . The host cell of claim 14 , wherein the plant cell is Nicotiana benthamiana. 18 . The host cell of claim 15 , wherein the plant cell is Nicotiana benthamiana. 19 . A method for producing a podophyllotoxin intermediate and derivative in a host cell, comprising culturing and transforming the host cell with one or more of the nucleic acid molecules according to any of claims 1 - 10 , adding starting material suitable to produce the podophyllotoxin intermediate and derivative to culture medium; and recovering the podophyllotin intermediate and derivative from culture medium. 20 . The method of claim 19 , wherein the host cell is a plant, yeast, bacterial, insect or mammalian cell. 21 . A method for producing 4′-desmethyl-epipodophyllotoxin in a host cell, comprising culturing and transforming the host cell with nucleic acid SEQ ID NO:1 for converting pinoresinol to secoisolariciresinol; nucleic acid SEQ ID NO:2 for converting secoisolariciresinol to matairesinol; nucleic acid SEQ ID NO:3 for converting matairesinol to pluviatolide; nucleic acid SEQ ID NO:4 for converting pluviatolide to 5′-desmethoxy-yatein; nucleic acid SEQ ID NO:5 for converting 5′-desmethoxy-yatein into 5′-desmethyl-yatein; nucleic acid SEQ ID NO:6 for converting 5′-desmethyl-yatein into yatein; nucleic acid SEQ ID NO:7 for converting yatein into deoxypodophyllotoxin; nucleic acid SEQ ID NO:8 for converting deoxypodophyllotoxin into 4′-desmethyl-deoxypodophyllotoxin; and nucleic acid SEQ ID NO:9 for converting 4′-desmethyl-deoxypodophyllotoxin into 4′-desmethyl-epipodophyllotoxin; adding pinoresinol as starting material to culture medium; and recovering 4′-desmethylepipodophyllotoxin from culture medium. 22 . The method of claim 21 , wherein the host cell is a plant, yeast, bacterial, insect or mammalian cell. 23 . The method of claim 21 , wherein the host cell furthermore comprises nucleic acid SEQ ID NO:10 or a conservative variant thereof.
Methyltransferases (2.1.1) · CPC title
Heterocyclic compounds containing oxygen atoms as the only ring heteroatoms in the condensed system, e.g. Salinomycin, Septamycin · CPC title
acting on the CH-CH group of donors (1.3) · CPC title
Flavone 3'-O-methyltransferase (2.1.1.42) · CPC title
with NADH or NADPH as one donor, and incorporation of one atom of oxygen 1.14.13 · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.